Taylor R Kavanagh Selected Research

Sphingosine-1-Phosphate Receptors

1/2020

Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taylor R Kavanagh Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 01/2018
3	Tuberous Sclerosis (Bourneville's Disease) 01/2020 - 01/2018
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020 - 12/2018
1	Neoplasms, Cystic, Mucinous, and Serous 03/2024
1	Carcinoma (Carcinomatosis) 03/2024
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2023
1	Papillary Thyroid Cancer 01/2021
1	Hamartoma 01/2020
1	Carcinogenesis 01/2020
1	Angiomyolipoma 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

3	trans-sodium crocetinate (crocetin)IBA 01/2020 - 01/2018
2	lipoarabinomannan (LAM)IBA 01/2020 - 12/2018
1	Colloids (Colloid)IBA 03/2024
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	VemurafenibIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Acetyl-CoA CarboxylaseIBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2020
1	Lysophosphatidic Acid ReceptorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Sirolimus (Rapamycin)FDA Link 12/2018
1	MTOR InhibitorsIBA 12/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	TransferasesIBA 01/2018

Therapy/Procedure

2	Therapeutics 12/2018 - 01/2018
1	Neoadjuvant Therapy 03/2024
1	Length of Stay 01/2023
1	Pancreaticoduodenectomy 01/2023